Serotonin News and Research

Latest Serotonin News and Research

Novel method of gene therapy promises to transform the treatment of rare genetic disorder

A novel method of gene therapy is helping children born with a rare genetic disorder called AADC deficiency that causes severe physical and developmental disabilities.

12 Jul 2021

Non-toxic derivative of tetanus neurotoxin may help treat depression, neurodegenerative diseases

Depression has been treated traditionally with inhibitors of serotonin reuptake in the central nervous system.

9 Jul 2021

Prenatal THC and CBD exposure impairs offspring's ability to respond to fluoxetine

Scientists at Indiana University have found that significant amounts of the two main components of cannabis, THC and CBD, enter the embryonic brain of mice in utero and impair the mice's ability as adults to respond to fluoxetine, a drug commonly used to treat anxiety and depression and known by the brand name Prozac.

1 Jul 2021

Declining sense of smell among older adults is more complex than previously believed

Contrary to what science once suggested, older people with a declining sense of smell do not have comprehensively dampened olfactory ability for odors in general - it simply depends upon the type of odor.

1 Jul 2021

New drug candidate may reduce anxiety-like behavior in mice

Anxiety, commonly termed as a feeling of fear, dread, and restlessness, is a perfectly normal reaction to stressful situations. However, a state of heightened anxiety, which is the reality for thousands of people who struggle to cope with these feelings, is called anxiety disorder.

29 Jun 2021

New analysis links distinct patterns of genetic mutations with OCD

In the first analysis of its kind, researchers at Columbia University Vagelos College of Physicians and Surgeons and several other institutions have linked distinct patterns of genetic mutations with obsessive-compulsive disorder (OCD) in humans.

28 Jun 2021

Study explores the potential role of gene polymorphisms in pathogenesis of prostate cancer

Oncotarget published "The presence of polymorphisms in genes controlling neurotransmitter metabolism and disease prognosis in patients with prostate cancer: a possible link with schizophrenia" reported that polymorphisms of neurotransmitter metabolism genes were studied in patients with prostate cancer (PC) characterized by either reduced or extended serum prostate-specific antigen doubling time corresponding to unfavorable and favorable disease prognosis respectively.

28 Jun 2021

Study delves into the link between smoking and suicidal behaviors

Psychiatry and Clinical Psychology residents Iván Echeverria, Miriam Cotaina and Antonio Jovani, from the Hospital Provincial of Castellón, doctor Ana Benito and doctor Gonzalo Haro from the TXP research group of the CEU UCH, and doctor Rafael Mora, have published the results of their latest research: a meta-analysis on suicide, the first cause of external death in Spain.

25 Jun 2021

Antidepressants taken during pregnancy do not increase risk for autism spectrum disorder

Women with depression and other mood disorders are generally advised to continue taking antidepressant medications during pregnancy.

24 Jun 2021

Study reviews natural drug candidates for potential treatment of COVID-19

A recent paper in the Saudi Journal of Biological Sciences seeks to open up new approaches by reviewing a list of compounds derived from plants and other natural sources, which have potential inhibitory activity against the coronavirus.

21 Jun 2021

Common antidepressant drugs help the immune system to attack tumors in mice

A class of drug called monoamine oxidase inhibitors is commonly prescribed to treat depression; the medications work by boosting levels of serotonin, the brain's "happiness hormone."

10 Jun 2021

Mast cell activation may underlie inflammation in severe COVID-19

A new preprint research paper posted to the medRxiv* server points to mast cells as major culprits in the etiology of severe and critical COVID-19. This could suggest suitable therapeutic and preventive interventions to reduce the morbidity and mortality of this viral illness.

3 Jun 2021

Research offers new hope for people affected by the microdeletion of chromosome 22

One person in 2000 suffers from a microdeletion of chromosome 22 that can lead to the development of psychotic disorders, such as schizophrenia, in adolescence.

1 Jun 2021

Study explains why it is difficult to withdraw from certain antidepressants

Researchers at the University of Illinois Chicago are a step closer to discovering why it is so difficult for people to withdraw from some antidepressant medications.

28 May 2021

Vagus nerve stimulation may be a potential adjunct therapy for COVID-19

COVID-19 was initially described as lung inflammation, or pneumonia, in older adults. However, we now know that SARS-CoV-2 infections can cause a wide range of symptoms in people of all ages, ranging from no symptoms at all to systemic inflammation and even death.

27 May 2021

New peptides allow cannabis-derived drugs to fight pain in mice without side effects

An international team, led by researchers from Pompeu Fabra University (UPF) in Barcelona, Spain, David Andreu and Rafael Maldonado, has developed a peptides family that allows delta-9-tetrahydrocannabinol (THC), the main component of Cannabis sativa, to fight pain in mice without side effects.

20 May 2021

Higher levels of inflammatory proteins in the blood are associated with aggressive traits

Aggression is common in many neuropsychiatric diseases, such as dementia, autism spectrum disorder, and schizophrenia.

18 May 2021

New peptide could allow cannabis to fight pain without side effects

Many people live with chronic pain, and in some cases, cannabis can provide relief. But the drug also can significantly impact memory and other cognitive functions.

12 May 2021

New genetically encoded sensor helps detect drugs of abuse

A genetically encoded sensor to detect hallucinogenic compounds has been developed by researchers at the University of California, Davis. Named psychLight, the sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse. The work is published April 28 in the journal Cell.

29 Apr 2021

Study highlights the psychological and social concerns of musculoskeletal trauma patients

Musculoskeletal injuries comprise a large percentage of hospital admissions for adults and often lead to chronic pain and long-term disability.

27 Apr 2021

Serotonin News and Research

Latest Serotonin News and Research

Novel method of gene therapy promises to transform the treatment of rare genetic disorder

Non-toxic derivative of tetanus neurotoxin may help treat depression, neurodegenerative diseases

Prenatal THC and CBD exposure impairs offspring's ability to respond to fluoxetine

Declining sense of smell among older adults is more complex than previously believed

New drug candidate may reduce anxiety-like behavior in mice

New analysis links distinct patterns of genetic mutations with OCD

Study explores the potential role of gene polymorphisms in pathogenesis of prostate cancer

Study delves into the link between smoking and suicidal behaviors

Antidepressants taken during pregnancy do not increase risk for autism spectrum disorder

Study reviews natural drug candidates for potential treatment of COVID-19

Common antidepressant drugs help the immune system to attack tumors in mice

Mast cell activation may underlie inflammation in severe COVID-19

Research offers new hope for people affected by the microdeletion of chromosome 22

Study explains why it is difficult to withdraw from certain antidepressants

Vagus nerve stimulation may be a potential adjunct therapy for COVID-19

New peptides allow cannabis-derived drugs to fight pain in mice without side effects

Higher levels of inflammatory proteins in the blood are associated with aggressive traits

New peptide could allow cannabis to fight pain without side effects

New genetically encoded sensor helps detect drugs of abuse

Study highlights the psychological and social concerns of musculoskeletal trauma patients

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Serotonin News and Research

Latest Serotonin News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in